HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabetta Liverani Selected Research

Elisabetta Liverani Research Topics

Disease

9Inflammation (Inflammations)
04/2023 - 09/2012
7Sepsis (Septicemia)
04/2023 - 01/2016
2Lung Injury
01/2017 - 01/2016
2Thrombosis (Thrombus)
01/2014 - 05/2012
1Atherosclerosis
04/2023
1COVID-19
04/2023
1Rheumatoid Arthritis
04/2023
1Neoplasms (Cancer)
04/2023
1Neuroinflammatory Diseases
04/2023
1Dysbiosis
01/2019
1Thrombocytopenia (Thrombopenia)
01/2018
1Pneumonia (Pneumonitis)
01/2016
1Acute Lung Injury
01/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2014
1Colitis
11/2014
1Fibrosis (Cirrhosis)
01/2013
1Hepatomegaly
01/2013
1Granuloma
01/2013
1Arthritis (Polyarthritis)
01/2013
1Autoimmune Diseases (Autoimmune Disease)
05/2011
1Infections
08/2004

Drug/Important Bio-Agent (IBA)

4Clopidogrel (Plavix)FDA Link
01/2021 - 01/2013
4Protein Kinase C-deltaIBA
01/2020 - 01/2018
4CytokinesIBA
02/2014 - 05/2011
4ThienopyridinesIBA
02/2014 - 01/2013
3salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2018
2Purinergic P2 Receptors (ADP Receptor)IBA
01/2022 - 01/2017
2Purinergic P2Y1 ReceptorsIBA
01/2022 - 01/2017
2Proteins (Proteins, Gene)FDA Link
11/2018 - 08/2004
2thienopyridineIBA
02/2014 - 01/2013
2Prasugrel HydrochlorideFDA Link
01/2013 - 01/2013
2Interleukin-17 (Interleukin 17)IBA
01/2013 - 05/2011
1TicagrelorIBA
01/2022
12- chloro- N6- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA
01/2022
1NucleotidesIBA
03/2020
1Interferon Type IIBA
01/2019
1Phenobarbital (Luminal)FDA Link
01/2019
1Protein Kinase CIBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1Peptides (Polypeptides)IBA
11/2018
1P-SelectinIBA
01/2018
1Adenosine Diphosphate (ADP)IBA
01/2017
1LipopolysaccharidesIBA
01/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017
1Sulfonic AcidsIBA
11/2014
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2014
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2013
1Interleukin-6 (Interleukin 6)IBA
01/2013
1Polysaccharides (Glycans)IBA
01/2013
1Chemokine CCL5IBA
01/2013
1Purinergic P2Y Receptor AntagonistsIBA
01/2013
1Peptidoglycan (Murein)IBA
01/2013
1Connective Tissue Growth FactorIBA
01/2013
1prednylidene (Pred)IBA
05/2012

Therapy/Procedure

5Punctures
01/2022 - 01/2018
5Ligation
01/2022 - 01/2018
3Therapeutics
04/2023 - 01/2017
1Drug Therapy (Chemotherapy)
01/2022